Tickerplace logo

Tickerplace

Kadimastem Ltd logo

NCELKadimastem Ltd

NCEL Stock Price, Valuation & Chart | Kadimastem Ltd

Compare
$3.350+0.06 (+1.82%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyNCEL intrinsic valueNCEL calculated fair value vs price
OverviewFinancialsDividendsRatios

NCEL Historical price chart

NCEL Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization1.51M
PE Ratio-0.6
EPS-5.55
Trading Volume3.50K
Today's High/Low3.49/3.33
Dividend Yield0.00
52 Week High/Low24.6/1.83
Shares Outstanding450.00K
NCEL Financial Statement
NCEL Analyst ratings
NCEL Analysis & performance metrics

NCEL Company profile

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative…

NCEL Management team

NCEL Frequently asked questions

What is Kadimastem Ltd (NCEL) Stock Price?

Current stock price of Kadimastem Ltd (NCEL) stock is $3.350. The stock price is +1.82% higher in the session. The intraday range can be seen from this page. Volume of Kadimastem Ltd (NCEL) stock is 3.50K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Kadimastem Ltd (NCEL) stock price going up or down today?

The stock price of Kadimastem Ltd (NCEL) can change with earnings, company news, and overall market sentiment. Kadimastem Ltd operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Kadimastem Ltd stock expensive at its current price?

Whether Kadimastem Ltd looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NCEL on this page is -0.60. EPS on this page is -5.55. Compare those figures with peers and growth expectations before deciding if the current Kadimastem Ltd price is justified.

How has the stock price of Kadimastem Ltd (NCEL) performed historically?

Historical performance for Kadimastem Ltd (NCEL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NCEL reacted to past earnings and market events.

Should I buy Kadimastem Ltd (NCEL) stock, at this price?

Buying Kadimastem Ltd (NCEL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.